CEO: Isaac E. Ciechanover

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Atara Biotherapeutics Inc is engaged in the development of pharmaceutical products. The company's focus lies on developing therapies addressing serious-life threatening diseases in the United States.


Key numbers

Market Capitalization:813889530
Shares Outstanding: 54151000
Float: 47986558
Next Earning Date:2020-03-02
TTm EPS: -6.0945
TTm Dividend Rate:
200 days moving average:18.47
50 days moving average: 14.98
One day percent Change: -6



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,